Administering medication transdermally offers several advantages over other methods of drug delivery.
Corindus Vascular Robotics has developed a robotic system to improve percutaneous coronary intervention (PCI) placement and reduce health risks to both the patient and the physician.
BioSante Pharmaceuticals may be known for its sexual health products such as LibiGel, but the Illinois-based company is also developing a novel immunotherapy vaccine to treat cancer.
Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
Biomoda’s CyPath diagnostic assay is based on molecular marker technology originally developed at the Los Alamos National Laboratory.
Below are some updates and developments from the past week.